← Shanghai Children's Medical Center International Department

Min Xu

Chief Physician

Oncology Ward II

Shanghai Children's Medical Center International Department

Chief Physician

The official SCMC page presents Xu Min as a pediatric oncology specialist focused on solid tumors and personalized treatment strategies driven by tumor biology.

Quick Answer

The official SCMC page presents Xu Min as a pediatric oncology specialist focused on solid tumors and personalized treatment strategies driven by tumor biology.

Main conditions handled

Hepatoblastoma · Neuroblastoma · Wilms tumor

Best for

Pediatric oncology · Solid tumor care · Multidisciplinary cancer treatment

Care approach

Multidisciplinary care of pediatric malignancy · Complex pediatric solid tumor surgery

Biography

According to the official page, Xu Min is a chief physician in Tumor Ward II. The page highlights basic research on childhood solid tumor occurrence and spread, early participation in multidisciplinary in-hospital pediatric malignancy care in China, extensive experience in complex pediatric solid tumor surgery, and overseas training at St. Jude and Schneider Children's Hospital in Israel.

Specialties

✓Pediatric solid tumors

✓Individualized treatment plans based on tumor biology

Practice Areas

•Pediatric oncology
•Solid tumor care
•Multidisciplinary cancer treatment

Conditions Treated

More experts for this condition

✓Hepatoblastoma

✓Neuroblastoma

✓Wilms tumor

✓Rhabdomyosarcoma

✓Lymphoma

✓Other pediatric solid tumors

Clinic Schedule

•Thursday morning (specialist clinic, Lujiazui)
•Monday morning (specialist clinic, Zhangjiang)
•Friday morning (VIP clinic, Zhangjiang)

Academic Titles

•Chief Physician

Academic Roles

•Lead expert in oncology
•Committee member of the Pediatric Committee of the China Anti-Cancer Association
•Committee member of the National Health Commission Expert Committee on Childhood Malignancies (solid tumors)
•Director of the Shanghai Anti-Cancer Association

Education & Overseas Experience

The official page notes further training at St. Jude in the US and Schneider Children's Hospital in Israel.

Research Highlights

•Research focuses on the occurrence and metastasis mechanisms of pediatric solid tumors
•Focuses on individualized treatment plans based on pediatric tumor biology
•Participated in organizing one diagnostic and treatment recommendation, standard, or guideline
•Published more than 30 papers, including 12 SCI-indexed papers

Signature Techniques

★Multidisciplinary care of pediatric malignancy
★Complex pediatric solid tumor surgery

Awards & Honors

★Third Prize, Science and Technology Progress Award of the China Anti-Cancer Association
★Second Prize, Innovation Project, 25th Shanghai Excellent Invention Selection Competition
★Bronze Award for Excellent Invention, 27th Shanghai Excellent Invention Selection Competition

International Patient Fit

Strong fit for international families seeking personalized pediatric solid-tumor treatment planning and multidisciplinary management in a tertiary oncology setting.

Frequently Asked Questions

Is this expert suitable for a second opinion?

Yes. Min Xu may be a strong option for second-opinion cases involving Pediatric solid tumors, Individualized treatment plans based on tumor biology, especially when families want input from a leading pediatric center in Shanghai.

What kinds of cases is this expert best for?

This expert is generally best suited for cases involving Hepatoblastoma, Neuroblastoma, Wilms tumor, based on the public SCMC profile and the doctor’s main clinical focus.

Can OriEast help arrange the appointment?

Yes. OriEast can help international families prepare records, confirm booking steps, and coordinate communication with Shanghai Children's Medical Center International Department when arranging care.

What records should patients prepare before booking?

Prepare the latest diagnosis, imaging or pathology reports, treatment summaries, medication list, and any key questions for the specialist. Clear English translations are helpful if available.